Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.49 |
| ▸ | CA2 | P00918 | 3/20 | 0.49 |
| ▸ | CA9 | Q16790 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | DRD2 | P14416 | 1/20 | 0.49 |
| ▸ | DRD4 | P21917 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.49 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.47 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10452634 | 0.89 | PTGS2 (0.55) | LMNAPTGS2CA1CA2KCNH2 | |
| SCHEMBL2565063 | 0.85 | PTGS2 (0.54) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL745595 | 0.85 | HSPB1 (0.50) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL9066838 | 0.85 | PTGS2 (0.54) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL17562364 | 0.82 | PTGS2 (0.51) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL2961207 | 0.82 | PTGS2 (0.51) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL2561971 | 0.82 | LMNA (0.47) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL13962353 | 0.82 | PTGS2 (0.51) | LMNAPTGS2CA1CA2MAPT | |
| SCHEMBL8746688 | 0.81 | LMNA (0.58) | LMNAPTGS2CA1CA2CA9 | |
| SCHEMBL6228523 | 0.81 | MAPT (0.65) | LMNAPTGS2DRD2DRD4DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008090555-A2 | MEDICAL DEVICES HAVING A MATRIX ADHERED THEREOF | ELUTEX LTD. (IL) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008090554-A2 | MODIFIED CONDUCTIVE SURFACES PREPARED BY ELECTROGRAFTING OF DIAZONIUM SALTS | ELUTEX LTD. (IL) | 2008-07-31 | — | — | WO | disclosed |
| US-7157601-B2 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | XEROX CORPORATION (US) | 2007-01-02 | — | — | US | disclosed |
| US-20060178531-A1 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | XEROX CORPORATION | 2006-08-10 | — | — | US | disclosed |
| US-7087752-B2 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | XEROX CORPORATION (US) | 2006-08-08 | — | — | US | disclosed |
| US-6860928-B2 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | XEROX CORPORATION (US) | 2005-03-01 | — | — | US | disclosed |
| US-20040249210-A1 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | XEROX CORPORATION | 2004-12-09 | — | — | US | disclosed |
| US-20040075723-A1 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | XEROX CORPORATION | 2004-04-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178531-A1 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | NR1H3, SIGMAR1, NCOR1 | LMNA 3943/4885PTGS2 3954/4885CA1 2655/4885 |
| US-20040249210-A1 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | NR4A1, NR0B1, RCOR1 | LMNA 2960/4885PTGS2 3855/4885CA1 2931/4885 |
| US-20040075723-A1 | Alkylated urea and triaminotriazine compounds and phase change inks containing same | NR4A1, NR1I3, CCNY | LMNA 1041/4885PTGS2 4181/4885CA1 2376/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.